TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/15/2025
Back to search
Official data from USPTO
CLINIMACS PRODIGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINIMACS PRODIGY
ST13
US500000079091389Class
1, 2, 5, 9, 10
Filing
79091389
Registration
4152205
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
07/20/2025
Trademark type
Word
Nice classes
1, 2, 5, 9, 10
Filing date
12/08/2010
Registration date
06/05/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2021
Last transaction
07/20/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Bergisch Gladbach, DE
Examiner
SAITO, KIM
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Miltenyi Biotec B.V. & Co. KG
Miltenyi Biotec GmbH
Representatives
Peter S. Sloane Leason Ellis LLP
Technical classification
Nice Classes
Class 1Class 2Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for scientific purposes
Class 2
Dyestuffs and colorants for pharmaceuticalmedical and scientific purposes
Class 5
Biochemicalbiological and chemical preparations for medical purposes for use in cellular therapy; cells for medical or clinical use
Class 9
laboratory apparatusan automated system for integrated cell processing from variable cell source to final product and parts and fittings therefor; reagents and other accessory items for use in laboratoriescytokines and monoclonal antibodies conjugated to superparamagnetic iron-dextran particles; magnetic cell separation system comprised of instruments for laboratory usea permanent magnetvalve and pump; disposables for laboratory useselection columntubing and bags for cell selectionpreparationseparation and collection; reagents and other accessory itemssuperparamagnetic iron-dextran particles and solutions for laboratory use
Class 10
Medical apparatus and instrumentsan automated system for integrated cell processing from variable cell source to final product and parts and fittings therefor; magnetic cell separation system comprised of instruments for medical usea permanent magnetvalve and pump; disposables for medical useselection columntubing and bags for cell selectionpreparationseparation and collection; reagents and other accessory itemssuperparamagnetic iron-dextran particles and solutions for medical use
Publications
History of USPTO decisions and trademark events.
57 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/15/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/15/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
07/27/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/16/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/28/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/16/2021
71AG
REGISTERED-SEC.71 ACCEPTED
08/16/2021
ES71
TEAS SECTION 71 RECEIVED
08/12/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/05/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/24/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/20/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/05/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/22/2019
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/03/2018
INPC
INVALIDATION PROCESSED
12/03/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/16/2018
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/16/2018
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
03/16/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/16/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
02/26/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/05/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/28/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/07/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/14/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/24/2012
FIMP
FINAL DISPOSITION PROCESSED
10/24/2012
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/06/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/05/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
06/05/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/20/2012
PUBO
PUBLISHED FOR OPPOSITION
03/20/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/29/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/15/2012
ALIE
ASSIGNED TO LIE
02/15/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/25/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/15/2011
GNRT
NON-FINAL ACTION E-MAILED
10/15/2011
CNRT
NON-FINAL ACTION WRITTEN
10/15/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2011
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/25/2011
RFNT
REFUSAL PROCESSED BY IB
04/17/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/25/2011
RFRR
REFUSAL PROCESSED BY MPU
03/24/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/24/2011
CNRT
NON-FINAL ACTION WRITTEN
03/23/2011
DOCK
ASSIGNED TO EXAMINER
03/14/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/12/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/12/2011
MAFR
APPLICATION FILING RECEIPT MAILED
01/25/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/21/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/13/2011
Continuous trademark protection
Get notified about every new filing that threatens CLINIMACS PRODIGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.